21 Feb 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Boston Scientific‘s Japanese subsidiary has join hands with Fukuda Denshi to market and sell the former's Spinal Cord Precision Plus System and accessories throughout Japan.
Fukuda Denshi's sales resources, distribution network and service capabilities are expected to enable Boston Scientific to reach substantially more accounts, customers and patients in Japan. Fukuda Denshi will begin distributing Boston Scientific neuromodulation products on April 1, 2013.
Boston Scientific is a leading developer of neuromodulation devices that are used to manage chronic neuropathic pain. Boston Scientific Spinal Cord Precision Plus System is a device with 16 dedicated, independent current sources designed to precisely target patient pain and is the only device to offer patients with wireless charging and wireless remote control to treat their pain. The remote controller is designed for patient ease-of-use.
"We are pleased to reach this agreement with Fukuda Denshi to distribute our neuromodulation products in Japan," said Mr Yusuke Naiki, president, Boston Scientific Japan. "Fukuda Denshi has been an established player in Japan for more than 70 years, with a proven track record and a long and successful history of delivering results. We look forward to a successful relationship."